X0306 4 2018-07-25 0 0001095981 CYTORI THERAPEUTICS, INC. CTYX 0001618670 Girao Tiago 3020 CALLAN ROAD SAN DIEGO CA 92121 0 1 0 0 VP & Chief Financial Officer Subscription Rights (Right to Buy) 1000.00 2018-07-25 4 X 0 1 D 2018-06-29 2018-07-20 See Footnote 0 D Series C Preferred Stock 0.7986 2018-07-25 4 X 0 1 A 2018-07-25 Common Stock 1253 1 D Warrants (Right to Buy) 0.7986 2018-07-25 4 X 0 1050 A 2021-01-25 Common Stock 1050 1050 D The preferred stock and the warrants reported on this Form 4 were acquired pursuant to the exercise of subscription rights previously distributed by Cytori Therapeutics, Inc. (the "Company") to all holders of the Company's common stock and Series B Preferred Stock on June 26, 2018. The subscription rights entitled each recipient to purchase units ("Units"). Each Unit consists of one share of the Company's Series C Preferred stock (convertible into 1,253 of the Company's common stock) and 1,050 warrants, with each warrant representing the right to purchase one share of the Company's common stock. The purchase price for each Unit was $1,000. The Series C Preferred Stock has no expiration date. Each warrant entitles the holder to purchase one share of the Company's common stock at an exercise price of $0.7986 through January 25, 2021. /s/ Tiago Girao 2018-07-27